Dangerous Drugs
Police Officer Accidentally Overdoses on Fentanyl Just by Touching It
During a routine traffic stop, East Liverpool, OH Officer Chris Green had worn gloves and a mask; there was white powder throughout the car, and he didn’t want to contaminate evidence. He had finished the search and removed his gloves, when another officer pointed out some powder on Green’s shirt. Without thinking, he brushed it…
Read MoreWatch The Full investigation on Friday, June 16th
“It’s immoral. It’s unethical. And it just has to be stopped.” Insys Therapeutics made millions off of patients suffering chronic pain. Their deceptive marketing practices for Subsys, a fentanyl opioid spray meant only for cancer patients, was prescribed to people throughout the country, who became addicted to the powerful drug. 9 Investigates looked into this…
Read MoreFDA Asks Endo Pharmaceuticals to Pull Opana ER Painkiller from the Market
By now, we are all fully aware of the opioid crisis that is gripping our nation. We have written about it, looked at its sources, listened to the doctors and the patients affected, and tried our best to share the facts about drugs like fentanyl. We believe that standing up for patients is the right…
Read MoreNew Jersey Gets Heat for Selective Scrutiny of Fentanyl Drug
In New Jersey, advocates are frustrated because the state has decided to only look into off-label usage. Many debates about whether off-label usage is ethical or should be legal have popped up, and the larger debate about Subsys rages on. In 2016, Senator Edward Markey of Massachusetts penned a letter about the dangers of Subsys…
Read MoreDangerous Drug Alert: What You Must Know about the Opioid Drug Subsys and the Way It Was Marketed to Users
Insys Therapeutics is the creator of a fentanyl opioid spray called Subsys. Subsys was approved by the Food & Drug Administration only for certain cancer patients for the management of breakthrough pain. A patient sprays Subsys under his or her tongue, which allows the medication to be absorbed immediately. Subsys is an incredibly powerful drug.…
Read MoreCompulsive Behavior Caused by Prescription and Generic Abilify Is Ruining Lives
In May 2015, Bristol-Meyers Squibb took a massive financial hit when their patent for the prescription drug Abilify (aripiprazole) expired. Prior to the patent expiration, Abilify was the best-selling drug in the nation; Bristol-Meyers Squibb sold nearly $6.5 billion of it in 2013. The drug, used to treat neurological conditions from depression to Tourette’s syndrome…
Read MoreFor Patients, the Difference Between the Right or Wrong Prescription Could Be a Sandwich
A new study published in JAMA Internal Medicine examined the links between pharmaceutical spending on entertaining doctors and the prescribing habits of those doctors. Unsurprisingly, the study found that doctors are more likely to prescribe a particular drug if a company spent money on activities like research, gifts, meals or travel. The surprising part was…
Read MoreWhat You Should Know about Chronic Pain Management
Chronic pain management is a risky business. Healthcare providers use powerful drugs like fentanyl to control chronic pain and increase your quality of life, but administering these drugs in proper doses requires precise balance. In addition to dosage, healthcare providers have to take the potential risks of long-term treatment into account. What are the dangers…
Read MoreJohnson & Johnson’s “Phantom Recall” of Defective Motrin Intentionally Deceived FDA
The Oregon Court of Appeals has recently revived interest in Johnson & Johnson’s 2009 “phantom recall” of Motrin pills. In late 2008, the drug maker discovered that a batch of the over the counter painkiller failed to dissolve properly, rendering the drug less effective. Instead of following proper procedure and notifying the Food and Drug…
Read MoreAre SSRI Anti-Depressants to Blame for a Child’s Autism?
As we see more and more children placed on the Autism Spectrum Disorder (ASD) each year, it becomes clearer that we, as a culture, need to explore the reasons behind why so many children are now being diagnosed. The latest data we have is from 2010, and it tells us that 1 in 68 children…
Read More